BioAge Labs Ownership | Who Owns BioAge Labs?
BioAge Labs Ownership Summary
BioAge Labs is owned by 89.47% institutional investors, 2.36% insiders, and 8.16% retail investors. Ah capital management is the largest institutional shareholder, holding 7.61% of BIOA shares. Vanguard Morn Total Stk Mkt Idx Investor is the top mutual fund, with 2.57% of its assets in BioAge Labs shares.
BIOA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | BioAge Labs | 89.47% | 2.36% | 8.16% |
| Sector | Healthcare Stocks | 245.07% | 12.10% | -157.17% |
| Industry | Biotech Stocks | 380.48% | 11.73% | -292.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ah capital management | 3.23M | 7.61% | $79.24M |
| Blackrock funding, inc. /de | 2.85M | 6.71% | $69.83M |
| Janus henderson group | 2.09M | 5.83% | $36.60M |
| Cormorant asset management, lp | 2.39M | 5.63% | $58.59M |
| Sofinnova investments | 2.29M | 5.40% | $56.22M |
| Tang capital management | 1.60M | 4.46% | $9.41M |
| Octagon capital advisors lp | 1.75M | 4.11% | $42.84M |
| Vanguard group | 1.41M | 3.95% | $18.72M |
| Ra capital management | 1.67M | 3.94% | $40.97M |
| Bioimpact capital | 1.67M | 3.93% | $40.87M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Pivotal bioventure partners investment advisor | 653.37K | 5.20% | $16.01M |
| Octagon capital advisors lp | 1.75M | 3.85% | $42.84M |
| Sands capital ventures | 786.35K | 3.14% | $19.27M |
| Cormorant asset management, lp | 2.39M | 3.00% | $58.59M |
| Sofinnova investments | 2.29M | 2.91% | $56.22M |
| Bioimpact capital | 1.67M | 2.49% | $40.87M |
| Stempoint capital lp | 464.17K | 1.96% | $11.38M |
| Yiheng capital management | 170.53K | 1.43% | $4.18M |
| Braidwell lp | 1.03M | 0.94% | $25.32M |
| Birchview capital, lp | 69.00K | 0.79% | $1.69M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Janus henderson group | 2.09M | 0.02% | 1.69M |
| Bioimpact capital | 1.67M | 2.49% | 1.67M |
| Blackrock funding, inc. /de | 2.85M | 0.00% | 581.32K |
| Nuveen | 349.14K | 0.00% | 300.45K |
| Integral health asset management | 300.00K | 0.29% | 300.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Suvretta capital management | - | - | -1.45M |
| Rtw investments, lp | - | - | -786.35K |
| Balyasny asset management | 702.86K | 0.02% | -624.69K |
| Cormorant asset management, lp | 2.39M | 3.00% | -500.00K |
| Redpoint management | - | - | -383.25K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Bioimpact capital | 1.67M | 2.49% | 1.67M | $40.87M |
| Integral health asset management | 300.00K | 0.29% | 300.00K | $7.35M |
| Sixth street partners management company | 273.37K | 0.00% | 273.37K | $6.70M |
| Ikarian capital | 200.00K | 0.53% | 200.00K | $4.90M |
| Yiheng capital management | 170.53K | 1.43% | 170.53K | $4.18M |
Sold Out
| Holder | Change |
|---|---|
| Mai capital management | -6.00 |
| Mendota financial group | -10.00 |
| Clearstead advisors | -18.00 |
| Fortitude family office | -27.00 |
| Principal securities | -41.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 163 | 10.14% | 38,008,982 | 10.85% | 89 | 0.98% | 92 | -4.17% | 37 | 32.14% |
| Mar 31, 2026 | 69 | -39.47% | 8,013,462 | -66.13% | 22 | 0.51% | 42 | -39.13% | 12 | -50.00% |
| Dec 31, 2025 | 65 | -31.58% | 10,078,271 | -52.59% | 28 | 0.80% | 41 | -6.82% | 11 | -47.62% |
| Sep 30, 2025 | 92 | 10.84% | 21,046,072 | 1.59% | 58 | 1.76% | 42 | -23.64% | 20 | 122.22% |
| Jun 30, 2025 | 83 | 27.69% | 20,716,579 | 2.74% | 57 | 1.83% | 55 | 77.42% | 9 | -50.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Morn Total Stk Mkt Idx Investor | 1.14M | 2.57% | 155.10K |
| Vanguard Total Stock Mkt Idx Inv | 1.14M | 2.57% | 155.10K |
| Vanguard MStar Total Stk Mkt Idx Invest | 1.14M | 2.49% | - |
| Polar Capital Biotech S Inc | 1.02M | 2.28% | - |
| iShares Russell 2000 ETF | 895.70K | 1.95% | -15.94K |
| Vanguard Institutional Extnd Mkt Idx Tr | 368.54K | 0.80% | 675.00 |
| Fidelity Small Cap Index | 300.89K | 0.68% | 1.96K |
| State Street® SPDR® S&P® PhrmctlsETF | 297.20K | 0.65% | - |
| iShares Russell 2000 Value ETF | 292.06K | 0.64% | - |
| Franklin Biotechnology Discv A(acc)USD | 248.58K | 0.54% | 89.29K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 29, 2026 | Barton Shane | Principal Accounting Officer | Sell | $1.07M |
| Jun 30, 2026 | Barton Shane | Principal Accounting Officer | Sell | $509.18K |
| Apr 01, 2026 | RUBIN PAUL D | Chief Medical Officer | Sell | $157.08K |
| Mar 02, 2026 | RUBIN PAUL D | Chief Medical Officer | Sell | $150.89K |
| Feb 02, 2026 | RUBIN PAUL D | Chief Medical Officer | Sell | $139.37K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | 3 |
| 2026 Q1 | - | 8 |
| 2025 Q4 | - | 2 |
| 2025 Q3 | - | - |
| 2025 Q2 | - | - |
BIOA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools